Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00396188 · ClinicalTrials.gov registry record
Screening Aid to Identify Corneas That May Have Pathologies or Other Conditions
A clinical trial, sponsored by Carl Zeiss Meditec.
- Completed
- Registry status
- 769
- Enrollment target
NCT00396188: Completed study, sponsored by Carl Zeiss Meditec.
NCT00396188 is a clinical trial that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 769 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00396188 has completed, sponsored by Carl Zeiss Meditec.
- COMPLETED
- Registry status
- 769 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the ability of a proprietary software screening tool to discriminate normal corneas (front surface of the eye) from previously diagnosed corneal conditions (diseases/surgeries/pathologies) and to determine the repeatabiltity and reproducibility of the Atlas II corneal topographer in normal human corneas.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 769 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-02 |
What the finished NCT00396188 record still lists
NCT00396188 is an observational study that tracks outcomes without assigning an intervention. The registered 769 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00396188 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00396188 about?
NCT00396188 is a clinical study titled "Screening Aid to Identify Corneas That May Have Pathologies or Other Conditions". The purpose of this study is to determine the ability of a proprietary software screening tool to discriminate normal corneas (front surface of the eye) from previously diagnosed corneal conditions (diseases/surgeries/pathologies) and to determine the repeatabiltity and reproducibility of the Atlas ...
What is the current status of trial NCT00396188?
This trial is currently completed. The enrollment target is 769 participants. The study started on 2007-02. Estimated completion is 2008-02.
Who is sponsoring clinical trial NCT00396188?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05977348 · 770 participants · NA
Increasing Food Literacy in Preschoolers to Reduce Obesity Risk
- NCT06376994 · 770 participants · Phase 3
Multi-Center Clean Air Randomized Controlled Trial in COPD
- NCT06824467 · 770 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- NCT06907173 · 770 participants · Phase 3
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia